| Spatial transcriptomics at subspot resolution with BayesSpace E Zhao, MR Stone, X Ren, J Guenthoer, KS Smythe, T Pulliam, ... Nature Biotechnology 39 (11), 1375-1384, 2021 | 187 | 2021 |
| Merkel cell carcinoma in the age of immunotherapy: Facts and hopes A Colunga, T Pulliam, P Nghiem Clinical Cancer Research, clincanres. 0439.2017, 2017 | 81 | 2017 |
| Glycolysis, glutaminolysis and fatty acid synthesis are required for distinct stages of KSHV lytic replication EL Sanchez, TH Pulliam, TA Dimaio, AB Thalhofer, T Delgado, ... Journal of virology, JVI. 02237-16, 2017 | 73* | 2017 |
| Polyomavirus‐driven Merkel cell carcinoma: Prospects for therapeutic vaccine development S Tabachnick‐Cherny, T Pulliam, C Church, DM Koelle, P Nghiem Molecular carcinogenesis 59 (7), 807-821, 2020 | 37 | 2020 |
| Polybrominated diphenyl ethers: structure determination and trends in antibacterial activity H Liu, K Lohith, M Rosario, TH Pulliam, RD O’Connor, LJ Bell, CA Bewley Journal of natural products 79 (7), 1872-1876, 2016 | 30 | 2016 |
| Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management … ES Tarabadkar, T Fu, K Lachance, DS Hippe, T Pulliam, H Thomas, JY Li, ... Journal of the American Academy of Dermatology 84 (2), 340-347, 2021 | 26 | 2021 |
| BayesSpace enables the robust characterization of spatial gene expression architecture in tissue sections at increased resolution E Zhao, MR Stone, X Ren, T Pulliam, P Nghiem, JH Bielas, R Gottardo bioRxiv, 2020.09. 04.283812, 2020 | 16 | 2020 |
| Mixing and delivery of multiple controlled oxygen environments to a single multiwell culture plate M Yao, T Sattler, ZN Rabbani, T Pulliam, G Walker, MP Gamcsik American Journal of Physiology-Cell Physiology 315 (5), C766-C775, 2018 | 14 | 2018 |
| Intersection of two checkpoints: could inhibiting the DNA damage response checkpoint rescue immune checkpoint-refractory cancer? PH Goff, R Bhakuni, T Pulliam, JH Lee, ET Hall, P Nghiem Cancers 13 (14), 3415, 2021 | 12 | 2021 |
| 50 Merkel cell polyomavirus-specific CD8 T cells in blood, but not in tumors, correlate with immunotherapy response in merkel cell carcinoma T Pulliam, S Jani, L Jing, J Zhang, R Kulikauskas, C Church, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| 1045 High dimensional profiling of merkel cell polyomavirus-specific T cells in response to anti-PD-1 immunotherapy H Ryu, T Bi, K Sarkar, C Church, N Ramchurren, T Pulliam, S Fling, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| An intratumoral STING agonist-mediated clinical response in PD-L1-refractory MCC via an unexpected mechanism of action TH Pulliam, R Bhakuni, S Jani, K Smythe, B Seaton, L Tachiki, ... Journal of Investigative Dermatology 142 (10), 2839, 2022 | 1 | 2022 |
| Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma C Church, T Pulliam, N Longino, SY Park, KS Smythe, V Makarov, N Riaz, ... Journal for immunotherapy of cancer 10 (9), e005328, 2022 | 1 | 2022 |
| 292 Is it safe to discontinue immunotherapy after a response in merkel cell carcinoma? L Tachiki, L Zawacki, D Hippe, Y Moshiri, N Alexander, T Akaike, ... Journal of Investigative Dermatology 142 (8), S50, 2022 | 1 | 2022 |
| 434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an option E McClure, T Akaike, ET Huynh, N Harikrishnan, K Lachance, C Church, ... Journal of Investigative Dermatology 143 (5), S75, 2023 | | 2023 |
| 143 Genetic and transcriptional signatures of merkel cell carcinoma-specific B cells suggest a functional role in modulating cancer immunity AJ Remington, HJ Rodriguez, T Pulliam, MD Gray, JJ Taylor, P Nghiem Journal of Investigative Dermatology 143 (5), S24, 2023 | | 2023 |
| CD8+ T CELL CLONES FROM PRIOR SARS-CoV-2 INFECTION PREDOMINATE AFTER mRNA VACCINATION E Ford, K Mayer-Blackwell, L Jing, A Sholukh, R St Germain, T Pulliam, ... Topics in Antiviral Medicine, 142-143, 2023 | | 2023 |
| Tempered IL-2 Signals Program PD-1 Checkpoint Blockade-Responsive Stem-like Exhausted T Cells During Priming V Kalia, J Reed, A Khanna, R Toumi, H Xiao, T Pulliam, R Deo, P Nghiem, ... bioRxiv, 2023.05. 25.541936, 2023 | | 2023 |
| Immunotherapy response and resistance: Dominant mechanisms in Merkel cell carcinoma T Pulliam | | 2023 |
| INTRATUMORAL S100A8-TO-CD8 RATIO IN INFLAMED MERKEL CELL CARCINOMA TUMORS CORRELATES WITH RESPONSE TO PD-1 PATHWAY BLOCKADE S Tabachnick-Cherny, T Pulliam, HR Chevez, K Smythe, R Kulikauskas, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A1034-A1034, 2022 | | 2022 |
